Marker Systems Based on MicroRNA Gene Methylation for the Diagnosis of Stage I-II Breast Cancer
- 2 Downloads
Groups of microRNA genes, methylation of which is associated with the initial (I-II) stages of breast cancer, are determined, and new markers and marker systems for the disease diagnosis were created on the basis of these data. A total of 14 genes in which methylation was associated with breast cancer were identified with the use of methyl-specific PCR on a representative sample of 70 tumor specimens. Analysis of 46 specimens from patients with clinical stages I and II detected 9 genes (MIR-124-1, MIR-124-3, MIR-125b-1, MIR-129-2, MIR-132, MIR-148a, MIR-193a, MIR-34b/c, and MIR-9-3), in which methylation was associated with the initial stages of the disease. Using ROC analysis, we formed two systems including 6 markers each and detecting breast cancer at stages I-II with high sensitivity (89 and 91%) and specificity (88%) at AUC=0.92-0.93. These sets were validated on the total sample of 70 specimens including all disease stages; they showed 93 and 94% sensitivities, 88% specificity, and AUC=0.95. Highly sensitive systems of markers, based on microRNA gene methylation, were created for the diagnosis of breast cancer at stages I-II.
Key WordsmicroRNA genes hypermethylation breast cancer ROC analysis diagnostic marker systems
Unable to display preview. Download preview PDF.
- 1.Braga EA, Loginov VI, Burdennyi AM, Filippova EA, Pronina IV, Kurevlev SV, Kazubskaya TP, Kushlinskii DN, Utkin DO, Ermilova VD, Kushlinskii NE. Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer. Bull. Exp. Biol. Med. 2018;164(3):351-355. doi: https://doi.org/10.1007/s10517-018-3988-y CrossRefPubMedGoogle Scholar
- 2.Braga EA, Loginov VI, Pronina IV, Burdennyy AM, Kubatiev AA, Khodyrev DS, Rykov SV, Friedman MV, Kazubskaya TP, Kushlinskii NE. Upregulation of RHOA and NKIRAS1 genes in lung tumors is associated with loss of their methylation as well as with methylation of regulatory miRNA genes. Biochemistry (Moscow). 2015;80(4):483-494.CrossRefPubMedGoogle Scholar
- 3.Braga EA, Loginov VI, Filippova EA, Burdennyi AM, Pronina IV, Kazubskaya TP, Khodyrev DS, Utkin DO, Kushlinskii DN, Adamyan LV, Kuslinskii NE. Diagnostic Value of a Group of MicroRNA Genes Hypermethylated in Ovarian Carcinoma. Bull. Exp. Biol. Med. 2018;166(2):253-256. doi: https://doi.org/10.1007/s10517-018-4326-0 CrossRefPubMedGoogle Scholar
- 4.Malignant Neoplasms in Russia in 2017 (Morbidity and Mortality). Karpin AD, Starinskii VV, Petrova GV, eds. Moscow, 2018. Russian.Google Scholar
- 6.Campos-Parra AD, Mitznahuatl GC, Pedroza-Torres A, Romo RV, Reyes FIP, López-Urrutia E, Pérez-Plasencia C. Micro-RNAs as potential predictors of response to breast cancer systemic therapy: future clinical implications. Int. J. Mol. Sci. 2017;18(6). pii: E1182. doi: 10.3390/ijms18061182CrossRefPubMedCentralGoogle Scholar
- 14.WHO Classification of Tumours of Female Reproductive Organs. Kurman RJ, Carcangiu ML, Herrington CS, Young RH, eds. Lyon, 2014.Google Scholar